HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

‘General Benefit’ Insufficient For EU Food For Special Medical Purposes Classification

Executive Summary

In a case that could have far-reaching implications for the region's food supplement manufacturers, the European Court of Justice has ruled that the definition of foods for special medical purposes should be restricted to use in addressing a specific nutrient deficiency related to an illness, as defined by EU law.

You may also be interested in...



Nestlé Discovers Gut Bacteria Strain Suggesting Opportunities For Infant Nutrition

Scientists at Nestlé’s research division think that they have found new bifidobacterium longum strains that have unique ability to utilize both key components of human milk and fibers from solid food, opening up new opportunities for “next generation nutritional solutions” like probiotics targeting the crucial weaning period of child development.

UK Pharmacies Recommending Short-Term Treatments Over PPIs For Frequent Heartburn – Haleon Survey

Haleon data shows a notable increase in UK pharmacy teams recommending PPIs for frequent heartburn in the year ended September 2022. However, pharmacies are still recommending alginate-based OTCs and antacids over PPIs for frequent heartburn in the majority of occasions, which Haleon says points to a need for more pharmacy education.

Europe's Botanicals Deadlock ‘Unlawful,’ Claims Industry Lawyer

The European Commission’s obvious passivity” with regards to the long-standing botanical health claims deadlock is illegal and violates the provisions of the EU Health Claims Regulation,” argues the German Pharmaceutical Industry Association, on the basis of a legal opinion provided by former constitutional judge Udo Di Fabio.

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS153129

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel